Cargando…

Strategies for purging CD96(+) stem cells in vitro and in vivo: New avenues for autologous stem cell transplantation in acute myeloid leukemia

The persistence of leukemic stem cells (LSCs) in acute myeloid leukemia (AML) patients receiving chemotherapy may be responsible for the high frequency of relapse. The selective elimination of CD96(+) AML-LSCs by means of CD96-specific monoclonal antibodies may be a promising therapeutic approach an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staudinger, Matthias, Humpe, Andreas, Gramatzki, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716745/ https://www.ncbi.nlm.nih.gov/pubmed/23894710 http://dx.doi.org/10.4161/onci.24500

Ejemplares similares

Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini-Antibodies Directed against the AML Stem Cell Antigen CD96
por: Mohseni Nodehi, Sahar, et al.
Publicado: (2012)

Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotype
por: Kellner, Christian, et al.
Publicado: (2013)

Boosting leukemia-specific T cell responses in patients following stem cell transplantation
por: Burkhardt, Ute E, et al.
Publicado: (2013)

Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: A double-edged sword?
por: Le Blanc, Katarina, et al.
Publicado: (2013)

A co-stimulatory trap set by myeloid leukemia cells
por: Esendagli, Gunes
Publicado: (2013)

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Invariant natural killer T cells reconstitution and the control of leukemia relapse in pediatric haploidentical hematopoietic stem cell transplantation
por: Casorati, Giulia, et al.
Publicado: (2012)

Emerging role of CD300 receptors in regulating myeloid cell efferocytosis
por: Voss, Oliver H, et al.
Publicado: (2015)

Targeting cathepsin G in myeloid leukemia
por: Alatrash, Gheath
Publicado: (2013)

A “vicious cycle” of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?
por: Schmiedel, Benjamin Joachim, et al.
Publicado: (2013)

Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells
por: Ségal-Bendirdjian, Evelyne, et al.
Publicado: (2014)

Acute myeloid leukemia therapeutics: CARs in the driver’s seat
por: Mardiros, Armen, et al.
Publicado: (2013)

Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
por: Horibata, Sachi
Publicado: (2019)

Cytotoxic T lymphocytes: Sniping cancer stem cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2012)

Targeting cancer stem cells via dendritic-cell vaccination
por: Teitz-Tennenbaum, Seagal, et al.
Publicado: (2012)

Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia
por: Kellner, Christian, et al.
Publicado: (2018)

Interferon α may be back on track to treat acute myeloid leukemia
por: Smits, Evelien L.J.M., et al.
Publicado: (2013)

Engineering hematopoietic stem cells to create melanoma specific CTL
por: Vatakis, Dimitrios
Publicado: (2012)

Regulation of cancer stem-like cell differentiation by Smac mimetics
por: Fulda, Simone
Publicado: (2014)

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer
por: Herr, Ingrid, et al.
Publicado: (2012)

Osteopontin, a possible modulator of cancer stem cells and their malignant niche
por: Rao, Guanhua, et al.
Publicado: (2013)

NORRIN plays a context-dependent role in glioblastoma stem cells
por: El-Sehemy, Ahmed, et al.
Publicado: (2020)

IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2014)

Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia
por: Williams, Mark S., et al.
Publicado: (2020)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Targeting cancer stem cells with ALDH1A1-based immunotherapy
por: DeLeo, Albert B.
Publicado: (2012)

A path from melanocyte stem cells to cutaneous melanoma illuminated by UVB
por: Moon, Hyeongsun, et al.
Publicado: (2018)

Linking PRMT5 to breast cancer stem cells: New therapeutic opportunities?
por: Chiang, Kelly, et al.
Publicado: (2018)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
por: Arina, Ainhoa
Publicado: (2014)

Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments
por: Jinushi, Masahisa
Publicado: (2014)

The other face of TLR3: A driving force of breast cancer stem cells
por: Jia, Deyong, et al.
Publicado: (2015)

Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis
por: Lim, Su Yin, et al.
Publicado: (2013)

The cancer stem cell phenotype: You can't win until you learn how to lose it
por: Lopez-Bertoni, Hernando, et al.
Publicado: (2015)

New insights on the role of CD8(+)CD57(+) T-cells in cancer
por: Wu, Richard C., et al.
Publicado: (2012)

Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity
por: Schendel, Dolores J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f7f5455tb0nu26bqk55i7qrrrd